Severe preeclampsia and eclampsia (PE/E) are among the leading causes of maternal death and disability worldwide. Magnesium sulfate is the treatment recommended by the World Health Organization, but it remains underutilized due to difficult administration. PATH designed a mobile application for dosing and dilution of magnesium sulfate to address the challenges of correctly calculating magnesium sulfate dosage given multiple concentrations and a complex dosing regimen.
Corporate author(s): PATH
Publication date: May 2014
206 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
- About PATH's work > Advancing technologies
- About PATH's work > Strengthening health systems
- Health technologies > Miscellaneous
- Maternal and child health > Safe birth and newborn care
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA